Individual and small group health plans faced losses in 2025 as medical claims continued to climb, accelerating a shift toward alternative benefit models.

The state's attorney general seeks documents on reimbursement rates, patient steering and pharmacy contracts as scrutiny of pharmacy benefit managers continues to intensify.

Among the districts surveyed, 81% reported health insurance premium increases of at least 10% over the past year, while 16% experienced increases exceeding 20%.

The agreement blocks contract terms regulators said limited insurers' ability to offer narrow networks, tiered plans and other cost-management tools.

Proposed legislation would direct HHS to establish compensation limits and require more disclosure around payments tied to Medicare Advantage enrollment.

Judge orders defense to disclose details of mental health evidence ahead of state trial.

GLP-1 medications prescribed for obesity could generate nearly $193,000 in lifetime economic and health value per patient while delivering outsized benefits to populations that have historically faced greater barriers to weight management, according to a new working paper from the National Bureau of Economic Research.

According to the report, employer spending on GLP-1 drugs doubled in a single year, rising from $11 to $24 per member per month. GLP-1s now account for 10.5% of all prescription drug claims, up from 6.9% in 2023.